245 related articles for article (PubMed ID: 10441368)
21. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
22. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
[TBL] [Abstract][Full Text] [Related]
23. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres.
Atkins TW; Peacock SJ; Yates DJ
J Microencapsul; 1998; 15(1):31-44. PubMed ID: 9463805
[TBL] [Abstract][Full Text] [Related]
24. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
25. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
Pérez C; Griebenow K
Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
[TBL] [Abstract][Full Text] [Related]
26. A novel preparation method for PLGA microspheres using non-halogenated solvents.
Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
[TBL] [Abstract][Full Text] [Related]
27. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
[TBL] [Abstract][Full Text] [Related]
28. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
29. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
Eniola AO; Hammer DA
Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
[TBL] [Abstract][Full Text] [Related]
30. Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds.
Sander EA; Alb AM; Nauman EA; Reed WF; Dee KC
J Biomed Mater Res A; 2004 Sep; 70(3):506-13. PubMed ID: 15293325
[TBL] [Abstract][Full Text] [Related]
31. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
Fischer S; Uetz-von Allmen E; Waeckerle-Men Y; Groettrup M; Merkle HP; Gander B
Biomaterials; 2007 Feb; 28(6):994-1004. PubMed ID: 17118442
[TBL] [Abstract][Full Text] [Related]
32. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide).
Berkland C; Pack DW; Kim KK
Biomaterials; 2004 Nov; 25(25):5649-58. PubMed ID: 15159081
[TBL] [Abstract][Full Text] [Related]
33. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
34. Ammonolysis-induced solvent removal: a facile approach for solidifying emulsion droplets into PLGA microspheres.
Kim J; Hong D; Chung Y; Sah H
Biomacromolecules; 2007 Dec; 8(12):3900-7. PubMed ID: 18031011
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
36. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
37. Surface modification of PLGA microspheres.
Müller M; Vörös J; Csúcs G; Walter E; Danuser G; Merkle HP; Spencer ND; Textor M
J Biomed Mater Res A; 2003 Jul; 66(1):55-61. PubMed ID: 12833431
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactide-co-glycolide) microspheres as a moldable scaffold for cartilage tissue engineering.
Mercier NR; Costantino HR; Tracy MA; Bonassar LJ
Biomaterials; 2005 May; 26(14):1945-52. PubMed ID: 15576168
[TBL] [Abstract][Full Text] [Related]
39. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. I. Preparation and characterization.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):283-92. PubMed ID: 15227673
[TBL] [Abstract][Full Text] [Related]
40. Properties of multiphase microspheres of poly(D,L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique.
O'Donnell PB; Iwata M; McGinity JW
J Microencapsul; 1995; 12(2):155-63. PubMed ID: 7629658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
